BMC MUSCULOSKELETAL DISORDERS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2025-02-10 ms5000001422398461

editor invited 12天了，依然没有变化，这是怎么回事呢

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2025-03-08 ms1000000437049473 来自广东省

前往app查看评论内容

3 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-12-31 SCI快到碗里来. 来自天津

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：生物信息学;单细胞;骨科
经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。

Submission received
07 Feb 2024
Technical check
Submission status Date
Submission is under technical check
07 Feb 2024
Amendment requested
14 Feb 2024
Amendment received
14 Feb 2024
Submission passed technical check
14 Feb 2024
Editorial assignment
Submission status Date
Ready for editorial assignment
14 Feb 2024

With editor
Submission status Date
Editor assigned
21 Aug 2024
Peer review
Submission status Date
First reviewer(s) invited
02 Sep 2024
Reviewer(s) accepted
01 Nov 2024
Reviewer report(s) received
11 Nov 2024

Revision requested
26 Nov 2024
Revision received
04 Dec 2024
Submission passed technical check
06 Dec 2024

First reviewer(s) invited
08 Dec 2024
Reviewer(s) accepted
08 Dec 2024
Reviewer report(s) received
09 Dec 2024

Submission accepted
Submission status Date
Submission accepted
27 Dec 2024

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-11-16 ms1000001788822136 来自上海

接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。
该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-11-16 ms1000001788822136 来自上海

投稿命中率:50.0
经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。
平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。

35 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-11-15 ms1000002038738018 来自陕西省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：脊柱;骨科;Orthopaedic
经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete

30 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2022-11-09 ms3000000919382660

偏重的研究方向：骨科;骨性关节炎
经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭

265 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-10-18 ms8000000515036802 来自陕西省

精彩评论，需要您登录查看

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-05-25 Win Victory 来自浙江省

投稿命中率:50.0
偏重的研究方向：骨科 MR分析
经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下

Submission under peer review
15 Apr 2024
Technical check
Submission status Date
Submission passed technical check
15 Apr 2024
Amendment received
14 Apr 2024
Submission is under technical check
12 Apr 2024
Submission received
Submission status Date
Submission received
12 Apr 2024

126 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2251349, encodeId=345d2251349a7, content=editor invited 12天了，依然没有变化，这是怎么回事呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=117f9581640, createdName=ms5000001422398461, createdTime=Mon Feb 10 21:35:06 CST 2025, time=2025-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2255176, encodeId=4c3622551e6df, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d66f9292267, createdName=ms1000000437049473, createdTime=Sat Mar 08 09:05:01 CST 2025, time=2025-03-08, status=0, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2245683, encodeId=28d022456830e, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：生物信息学;单细胞;骨科 经验分享：纯生信，单细胞挖掘的，遇见了心软的审稿人和编辑。邀请了2个审稿人，第一个感觉是用chatGPT审稿，第二个比较专业，好在问题不是很尖锐，修了一次后接收了。 Submission received 07 Feb 2024 Technical check Submission status Date Submission is under technical check 07 Feb 2024 Amendment requested 14 Feb 2024 Amendment received 14 Feb 2024 Submission passed technical check 14 Feb 2024 Editorial assignment Submission status Date Ready for editorial assignment 14 Feb 2024 With editor Submission status Date Editor assigned 21 Aug 2024 Peer review Submission status Date First reviewer(s) invited 02 Sep 2024 Reviewer(s) accepted 01 Nov 2024 Reviewer report(s) received 11 Nov 2024 Revision requested 26 Nov 2024 Revision received 04 Dec 2024 Submission passed technical check 06 Dec 2024 First reviewer(s) invited 08 Dec 2024 Reviewer(s) accepted 08 Dec 2024 Reviewer report(s) received 09 Dec 2024 Submission accepted Submission status Date Submission accepted 27 Dec 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231029/86c12592c21b40c0b809845881d1943d/0731d246fce3455b840bc7addad2a73c.jpg, createdBy=77c35470173, createdName=SCI快到碗里来., createdTime=Tue Dec 31 09:53:13 CST 2024, time=2024-12-31, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2237312, encodeId=3673223e31282, content=接受多种类型的稿件，包括研究论文、数据库文章、软件文章、病例报告等。因此，作者在投稿前应仔细阅读投稿威廉亚洲博彩公司，确保稿件符合期刊的接收范围。 该期刊为开放获取期刊，尤其适合从事肌肉骨骼疾病研究的学者。平均审稿周期在3周左右，由于期刊采用英文发表，建议投稿者确保文章的语言质量。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 23:11:40 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237305, encodeId=c62b223e30559, content=投稿命中率:50.0 经验分享：该期刊接受多种类型的稿件，包括研究论文、综述、技术进步论文、数据库文章、软件文章、病例报告等。主要研究方向涵盖骨科、风湿病学、病理生理学、分子遗传学和流行病学等领域。尤其适合从事骨科和风湿病学研究的学者。 平均审稿速为3周（特殊情况下，最慢要三个月），从提交到接受的平均时间为143天。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822136, createdTime=Sat Nov 16 22:22:07 CST 2024, time=2024-11-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2237015, encodeId=4829223e01581, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：脊柱;骨科;Orthopaedic 经验分享：Submission history Submission received Submission status Date Submission received 30 Jun 2024 Technical check Submission status Date Submission is under technical check 30 Jun 2024 Amendment requested 01 Jul 2024 Amendment received 01 Jul 2024 Submission passed technical check 04 Jul 2024 Editorial assignment Submission status Date Ready for editorial assignment 04 Jul 2024 With editor Submission status Date Editor assigned 04 Jul 2024 Revision requested 10 Jul 2024 Revision received 13 Jul 2024 Submission passed technical check 01 Aug 2024 Peer review Submission status Date First reviewer(s) invited 06 Aug 2024 Reviewer(s) accepted 06 Aug 2024 Reviewer report(s) received 08 Aug 2024 Revision requested 19 Aug 2024 Revision received 01 Sep 2024 Submission passed technical check 11 Sep 2024 First reviewer(s) invited 13 Sep 2024 Reviewer(s) accepted 14 Sep 2024 Reviewer report(s) received 22 Sep 2024 Revision requested 30 Sep 2024 Revision received 07 Oct 2024 Submission passed technical check 08 Oct 2024 First reviewer(s) invited 09 Oct 2024 Reviewer(s) accepted 11 Oct 2024 Reviewer report(s) received 23 Oct 2024 Revision requested 25 Oct 2024 Revision received 25 Oct 2024 Submission passed technical check 28 Oct 2024 Revision requested 05 Nov 2024 Revision received 05 Nov 2024 Submission passed technical check 05 Nov 2024 Revision requested 06 Nov 2024 Revision received 06 Nov 2024 Submission passed technical check 07 Nov 2024 Submission accepted Submission status Date Submission accepted 08 Nov 2024 Publishing and rights Submission status Date Submission is in publishing and rights 11 Nov 2024 Production Submission status Date Publishing and rights complete, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fa08145074, createdName=ms1000002038738018, createdTime=Fri Nov 15 01:54:34 CST 2024, time=2024-11-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2099480, encodeId=81922099480b4, content=偏重的研究方向：骨科;骨性关节炎 经验分享：Editors invited一般持续多长时间，10月21号开始Editors invited到现在已经将近20天了，还没有动静，要不要催催，求助😭😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=265, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1688361305, createdName=ms3000000919382660, createdTime=Wed Nov 09 21:16:05 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2231510, encodeId=e04022315108b, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：啥情况？有大咖说说吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=[AttachmentDto(url=https://img.medsci.cn/comment/0ecb3ede50d841d8ac027fba709b918b-ewGEMcqWssLu.jpeg, type=image, width=828, height=1794)], authenticateStatus=null, createdAvatar=null, createdBy=6dbb9492744, createdName=ms8000000515036802, createdTime=Fri Oct 18 10:30:41 CST 2024, time=2024-10-18, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2206590, encodeId=a558220659056, content=投稿命中率:50.0 偏重的研究方向：骨科 MR分析 经验分享：问下各位友友，目前 peer review 是算在外审了吗？还是在邀请审稿阶段？也40多天了，纠结要不要催下 Submission under peer review 15 Apr 2024 Technical check Submission status Date Submission passed technical check 15 Apr 2024 Amendment received 14 Apr 2024 Submission is under technical check 12 Apr 2024 Submission received Submission status Date Submission received 12 Apr 2024, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50772024401, createdName=Win Victory, createdTime=Sat May 25 22:33:26 CST 2024, time=2024-05-25, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2217402, encodeId=b19a221e40267, content=审稿速度:6.0 经验分享：是够慢的，虽然还是接收了，来来回回六七个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c468140547, createdName=ms2000002008843481, createdTime=Mon Jul 29 15:33:36 CST 2024, time=2024-07-29, status=1, ipAttribution=广东省)]

2024-07-29 ms2000002008843481 来自广东省

审稿速度:6.0
经验分享：是够慢的，虽然还是接收了，来来回回六七个月

105 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务